You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CLEAR

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Ovarian Clear Cell Carcinoma, Gynecologic Cancer Trial in Boston (Lenvatinib, Pembrolizumab)

Recruiting
  • Ovarian Clear Cell Carcinoma
  • Gynecologic Cancer
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Oct 13, 2022

Malocclusion, Class II Malocclusion Trial in Hama (clear aligners, traditional treatment Fixed appliances with class II

Recruiting
  • Malocclusion
  • Class II Malocclusion
  • clear aligners
  • traditional treatment Fixed appliances with class II elastics.
  • Hama, Syrian Arab Republic
    Hama University
Jan 12, 2023

Renal Cell Carcinoma Trial (HS-10516)

Not yet recruiting
  • Renal Cell Carcinoma
  • (no location specified)
Sep 24, 2023

Clear Cell Sarcoma Trial in El Segundo, Houston (AMG 337)

Terminated
  • Clear Cell Sarcoma
  • AMG 337
  • El Segundo, California
  • +1 more
Dec 9, 2022

Tooth Discoloration, Tooth Sensitivity, Gingivitis Trial in Tafalla (Whitening)

Recruiting
  • Tooth Discoloration
  • +3 more
  • Whitening
  • Tafalla, Navarra, Spain
    Clínica Dental Iturralde
Apr 18, 2023

Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma Trial in Chicago, Providence (Nivolumab, Ipilimumab)

Recruiting
  • Ovarian Cancer
  • +4 more
  • Chicago, Illinois
  • +3 more
Jan 26, 2023

Clear Cell Renal Cell Carcinoma Trial in Los Angeles (89Zr-DFO-girentuximab)

Available
  • Clear Cell Renal Cell Carcinoma
  • 89Zr-DFO-girentuximab
  • Los Angeles, California
    UCLA
Oct 12, 2023

Infectious Disease Trial (Start Antibiotics / Continue Antibiotics for treatment of bacteriuria, No Antibiotics for treatment of

Not yet recruiting
  • Infectious Disease
  • Start Antibiotics / Continue Antibiotics for treatment of bacteriuria
  • No Antibiotics for treatment of bacteriuria
  • (no location specified)
Aug 21, 2023

Non-clear Renal Cell Carcinoma Trial in Nanjing, Nanning (Toripalimab, Axitinib)

Recruiting
  • Non-clear Renal Cell Carcinoma
  • Nanjing, Jiangsu, China
  • +1 more
Mar 13, 2023

Myopia, Astigmatism Trial (CLEAR)

Not yet recruiting
  • Myopia
  • Astigmatism
  • CLEAR
  • (no location specified)
Jul 29, 2022

CLEAR-B: Cancer Landscape - Early Adjuvant Retrospective

Recruiting
  • Breast Cancer
  • +2 more
    • Erlangen, Germany
      Department of Gynecology and Obstetrics, Erlangen University Hos
    May 12, 2023

    Root Resorption Trial in Cairo (Leveling and alignment)

    Recruiting
    • Root Resorption
    • Leveling and alignment
    • Cairo, Or, Egypt
    • +1 more
    Jan 9, 2023

    Non-Clear Cell Renal Cell Carcinoma Trial in Duarte (XL092, Nivolumab, Sunitinib Malate)

    Recruiting
    • Non-Clear Cell Renal Cell Carcinoma
    • Duarte, California
      Exelixis Clinical Site #1
    Jan 13, 2023

    Advanced Cancer, Clear Cell Renal Cell Carcinoma Trial in Houston (177Lu girentuximab, Nivolumab, Cabozantinib)

    Not yet recruiting
    • Advanced Cancer
    • Clear Cell Renal Cell Carcinoma
    • 177Lu girentuximab
    • +3 more
    • Houston, Texas
      MD Anderson Cancer Center
    Dec 15, 2022

    Advanced Clear Cell Renal Carcinoma (Ccrcc), Papillary Renal Cell Carcinoma (Prcc) Trial run by the National Cancer Institute

    Not yet recruiting
    • Advanced Clear Cell Renal Carcinoma (Ccrcc)
    • Papillary Renal Cell Carcinoma (Prcc)
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Feb 2, 2023

    From Clear Cell Renal Cell Carcinoma

    Recruiting
    • Clear Cell Renal Cell Carcinoma
    • Urinary sample
    • Saint-Étienne, France
      Chu Saint-Etienne
    Jul 13, 2022

    ccRCC, Clear Cell Renal Cell Carcinoma, Kidney Cancer Trial (NKT2152, palbociclib, sasanlimab)

    Not yet recruiting
    • ccRCC
    • +20 more
    • (no location specified)
    Jul 6, 2023

    Renal Cell Carcinoma Trial in Houston (Tivozanib, Nivolumab)

    Not yet recruiting
    • Renal Cell Carcinoma
    • Houston, Texas
      M D Anderson Cancer Center
    Sep 19, 2023

    Renal Cell Carcinoma Trial in Guangzhou (Pucotenlimab Combined With Lenvatinib)

    Not yet recruiting
    • Renal Cell Carcinoma
    • Pucotenlimab Combined With Lenvatinib
    • Guangzhou, Other (Non U.s.), China
      Sun Yat-sen University Cancer Center
    Nov 10, 2023

    Carcinoma, Renal Cell Trial (Orellanine)

    Not yet recruiting
    • Carcinoma, Renal Cell
    • (no location specified)
    Jan 25, 2023

    Malocclusion, Angle Class I, Malocclusion; Displaced or Missing Teeth, Crowding Trial in Damascus (Fixed Appliances, Clear

    Completed
    • Malocclusion, Angle Class I
    • +2 more
    • Fixed Appliances
    • Clear Aligners
    • Damascus, Syrian Arab Republic
      Department of Orthodontics, University of Damascus Dental School
    Nov 11, 2022

    Clear Cell Renal Cell Carcinoma, Clear Cell Renal Cell Carcinoma Metastatic Trial in Iowa City (Selenomethionine (SLM),

    Recruiting
    • Clear Cell Renal Cell Carcinoma
    • Clear Cell Renal Cell Carcinoma Metastatic
    • Selenomethionine (SLM)
    • +2 more
    • Iowa City, Iowa
      University of Iowa Hospitals & Clinics
    Sep 19, 2022

    Crowding, Tooth Trial in Damascus (Clear aligners, Fixed appliances)

    Completed
    • Crowding, Tooth
    • Clear aligners
    • Fixed appliances
    • Damascus, Syrian Arab Republic
      University of Damascus
    Aug 11, 2022

    Sarcoma, Clear Cell Trial in United States (CPI-613 + Hydroxychloroquine)

    Recruiting
    • Sarcoma, Clear Cell
    • CPI-613 + Hydroxychloroquine
    • Duarte, California
    • +7 more
    Nov 10, 2022

    Juvenile Idiopathic Arthritis, Malocclusion, Angle Class II Trial in Milan (Device: orthodontic - mandibular advancement clear

    Not yet recruiting
    • Juvenile Idiopathic Arthritis
    • Malocclusion, Angle Class II
    • Device: orthodontic - mandibular advancement clear aligner
    • Milan, Itali, Italy
      Università di Milano, Ospedale maggiore Policlincio, IRCCS Cà Gr
    Jul 19, 2022